CHRAC1 Antikörper (C-Term)
Kurzübersicht für CHRAC1 Antikörper (C-Term) (ABIN7184722)
Target
Alle CHRAC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- CHRAC1 Antibody
-
Kreuzreaktivität
- Maus
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human CHRAC15.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CHRAC1 (Chromatin Accessibility Complex 1 (CHRAC1))
-
Andere Bezeichnung
- CHRAC1
-
Hintergrund
- CHARC1 antibody, CHARC15 antibody, CHRAC-1 antibody, CHRAC-15 antibody, Chrac1 antibody, CHRAC15 antibody, CHRC1_HUMAN antibody, Chromatin accessibility complex 1 antibody, Chromatin accessibility complex 15 kDa protein antibody, Chromatin accessibility complex protein 1 antibody, DNA polymerase epsilon subunit p15 antibody, histone-fold protein CHRAC15 antibody, HuCHRAC15 antibody, YCL1 antibody
-
UniProt
- Q9NRG0
Target
-